Natsar Pharmaceuticals is an applied research and drug development company focused on the development of novel treatments for cancer and other diseases. Our lead compound, RK-33, is a first in class DDX3 inhibitor which has shown great promise in pre-clinical studies in sarcoma, breast, brain, lung and other tumors. We look forward to beginning a phase 1 clinical program soon.
Company Details
- Employees
- 2
- Founded
- -
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- natsarpharmaceuticals.com
Natsar Pharmaceuticals Questions
Natsar Pharmaceuticals's website is natsarpharmaceuticals.com
Natsar Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/natsar-pharmaceuticals
Natsar Pharmaceuticals has
2 employees.
View email and phone details for 2
employees at Natsar Pharmaceuticals.
Natsar Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Natsar Pharmaceuticals's top competitors are
Leica Biosystems,
Natsar,
Eastern Engineered Wood Products,
Vishay Intertechnology, Inc.,
Metro Supply Chain,
Aarvik Therapeutics Inc,
Verge Genomics,
Infinity Bio, Inc.,
Ilham Capital Ventures.
Natsar Pharmaceuticals's categories are Pharmaceutical Manufacturing
Natsar Pharmaceuticals's founding year is 2016
